Researchers unveiled the crystal structure of the human dopamine D3 receptor in Science on November 19. This angstrom-resolution picture revealed key features that can be exploited in the quest to develop new therapeutic compounds for schizophrenia and other disorders.

Read this article at Schizophrenia Research Forum.